Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities

Published:2021-02 Issue:2 Volume:29 Page:555-570
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Shemesh Colby S.,Hsu Joy C.,Hosseini Iraj,Shen Ben-Quan,Rotte Anand,Twomey Patrick,Girish Sandhya,Wu Benjamin

Funder

Genentech

F. Hoffmann-La Roche

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference127 articles.

1. The dawn of vaccines for cancer prevention;Finn;Nat. Rev. Immunol.,2018

2. Evolution of cancer pharmacological treatments at the turn of the third millennium;Falzone;Front. Pharmacol.,2018

3. Cancer DNA vaccines: current preclinical and clinical developments and future perspectives;Lopes;J. Exp. Clin. Cancer Res.,2019

4. Is the “3+3” dose-escalation phase I clinical trial design suitable for therapeutic cancer vaccine development? A recommendation for alternative design;Rahma;Clin. Cancer Res.,2014

5. A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial;Tan;J. Immunother. Cancer,2015

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DIPAN: Detecting personalized intronic polyadenylation derived neoantigens from RNA sequencing data;Computational and Structural Biotechnology Journal;2024-12

2. Immunomodulatory metal-based biomaterials for cancer immunotherapy;Journal of Controlled Release;2024-11

3. In silico advancements in Peptide-MHC interaction: A molecular dynamics study of predicted glypican-3 peptides and HLA-A*11:01;Heliyon;2024-09

4. Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective;Vaccines;2024-08-22

5. Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy;Discover Oncology;2024-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3